Biocon Ltd

Biocon | 532523

Live

₹380.00

+₹5.62 (+1.50%)

As on 17/09/26, 7:21 PM

Market Cap61,015.75 CR

Current Price₹380

High / Low₹447.15 / 337.05

PE Ratio151.62

Book Value₹210.6

Dividend Yield0.14%

ROCE3.76%

ROE0.91%

Face Value₹2.00

Current Vol.30,43,285

Average Vol.---

ISININE376G01013

PB Ratio1.71

Debt to Equity0.61

Net Profit Margin2.2

Operating Margin22.04

BIOCON - Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹374.4₹374

₹380

Previous CloseToday's Open

₹337.05₹447.15

₹380

52W Low52W High

₹374Today's Open

₹374.4Previous Close

30,43,285Volume

₹337.0552W Low

₹447.1552W High

Ratios

No data available

About Company

Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company
At present, Company is engaged in the manufacture of biotechnology products and research services
Biocon Limited was incorporated in 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw
Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind
In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merged it with the subsidiary, Quest International
In 1994, the company had established the Syngene International Pvt
as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector
The commercial success of Biocon's proprietary fermentation plant led to a 3-fold expansion during 1996 and also in the same year, the company entered the biopharmaceuticals and statins
Biocon had commenced the business in the human healthcare in 1997 through a dedicated manufacturing facility
During the year 1998, Unilever inked a deal with ICI to sell its specialty chemicals division of which Quest International is a part

Ethics: Biocon Ltd is flagged for

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Strong

The company demonstrates strong ESG (Environmental, Social, and Governance) practices.

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI23.39

SMA 20402.26

SMA 50416.85

SMA 100412.88

SMA 200395.54

SMA 10391.78

MACD_12_26_Days-9.88

EMA10Day391.00

EMA20Day399.57

EMA50Day409.13

MACD_12_26_9_Days-2.36

EMA100Day407.45

EMA200Day397.73

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth10.91%

ROE1.34%

EBITDA Margin22.04%

All figures in ₹ Crores

Indicators	2026	2025	2024	2023	2022
Revenue	16,927.00	15,261.70	14,755.70	11,174.20	8,184.00
Interest	990.30	897.40	974.40	419.00	67.60
Expenses	13,471.70	12,095.40	11,541.20	8,829.50	6,420.70
Financing Profit	3,797.80	4,374.50	4,080.00	2,720.60	1,976.00
Financing Margin %	22%	29%	28%	24%	24%
Other Income	342.50	1,208.20	865.50	375.90	212.70
Depreciation	1,956.70	1,687.00	1,568.80	1,113.10	814.20
Profit before tax	447.90	1,886.60	1,525.20	897.10	983.10
Tax %	18%	24%	15%	28%	22%
Net Profit	368.80	1,429.40	1,297.80	643.00	771.60
EPS in Rs	2.82	8.46	8.55	3.88	5.44

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
SANATAN FINANCIAL ADVISORY SERVICES PRIVATE LIMITED	14 Jul ‘26	Purchase	6,26,000	₹400	1.46%
UTI MUTUAL FUND	14 Jul ‘26	Purchase	6,26,000	₹400	1.46%
ADITYA BIRLA SUNLIFE MUTUAL FUND	14 Jul ‘26	Purchase	12,50,000	₹400	2.91%
AXIS MAX LIFE INSURANCE LIMITED	14 Jul ‘26	Purchase	6,26,000	₹400	1.46%
AXIS MUTUAL FUND	14 Jul ‘26	Purchase	6,26,000	₹400	1.46%
BAJAJ LIFE INSURANCE LIMITED	14 Jul ‘26	Purchase	6,26,000	₹400	1.46%
BNP PARIBAS ARBITRAGE	14 Jul ‘26	Purchase	7,50,000	₹400	1.74%
CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED	14 Jul ‘26	Purchase	7,50,000	₹400	1.74%
EDELWEISS MUTUAL FUND	14 Jul ‘26	Purchase	6,26,000	₹400	1.46%
FRANKLIN TEMPLETON MUTUAL FUND	14 Jul ‘26	Purchase	9,37,500	₹400	2.18%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

06 Aug 2026

AGM

22 Jun 2026

03 Jul 2026

Final Dividend (₹0.5)

Board of Directors at its meeting held today, i.e. on Thursday, May 07, 2026, inter alia, has approved the following: Recommended final dividend at the rate of 10% i.e. Re. 0.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2026, subject to approval of the shareholders at the ensuing Annual General Meeting (AGM'). Pursuant to Regulation 42 of SEBI Listing Regulations, the Company has fixed Friday, July 03, 2026 as the record date for determining entitlement of shareholders to final dividend for the financial year ended March 31, 2026. The dividend will be paid on or before August 31, 2026.

07 May 2026

31 Dec 2025

EGM

06 Dec 2025

08 Aug 2025

AGM

08 May 2025

04 Jul 2025

Final Dividend (₹0.5)

Recommended a final dividend at the rate of 10% i.e. Re. 0.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2025, subject to Shareholders' approval at the ensuing Annual General Meeting ('AGM'). Pursuant to Regulation 42 of SEBI Listing Regulations, the Company has fixed Friday, July 04, 2025 as the record date for determining entitlement of Members to final dividend for the financial year ended March 31, 2025. The dividend will be paid on or before September 05, 2025.

08 May 2025

09 Aug 2024

AGM

16 May 2024

05 Jul 2024

Final Dividend (₹0.5)

Recommended a final dividend at the rate of 10% i.e. Re. 0.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2024, subject to shareholders' approval at the ensuing Annual General Meeting (AGM'). Pursuant to Regulation 42 of SEBI Listing Regulations, the Company has fixed Friday, July 5, 2024 as the record date for determining entitlement of Members to final dividend for the financial year ended March 31, 2024. The dividend will be paid on or before September 6, 2024.

16 May 2024

11 Aug 2023

AGM

23 May 2023

07 Jul 2023

Final Dividend (₹1.5)

The Board recommended a final dividend at the rate of 30% i.e. Rs. 1.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2023, subject to shareholders' approval at the ensuing Annual General Meeting ('AGM'). Pursuant to Regulation 42 of SEBI Listing Regulations, the Company has fixed Friday, July 7, 2023 as the record date for determining entitlement of members to final dividend for the financial year ended March 31, 2023. The dividend will be paid on or before September 8, 2023.

23 May 2023

28 Jul 2022

AGM

28 Apr 2022

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
374	60,959	83	2	22	1	2.20%
1,854	4,44,717	35	5	28	0	19.78%
9,200	2,44,223	82	15	71	0	24.32%
4,823	1,83,453	82	22	49	1	11.09%
1,105	1,10,224	23	4	17	0	9.82%
1,360	1,09,849	31	3	23	0	9.92%
1,906	1,02,984	94	19	65	1	13.06%
1,145	95,592	30	3	18	0	12.34%
1,641	94,420	25	2	17	0	10.41%
2,047	93,611	16	4	13	0	19.16%

Showing 10 of 136 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in just 5 minutes*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

HDFCBANKHDFC Bank Ltd
₹713-8.5 (-1.18%)

Group Stocks

Adani Stocks

Tata Group Stocks

Frequently Asked Questions

What is Share Price of Biocon Ltd?

The current share price of Biocon Ltd (Biocon) is ₹380.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Biocon Ltd?

The Price-to-Earnings (P/E) ratio of Biocon Ltd is 380.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Biocon Ltd?

Biocon Ltd has a 52-week high of ₹447.15 and a 52-week low of ₹337.05. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Biocon Ltd?

Biocon Ltd offers a dividend yield of 0.13%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Biocon Ltd?

The Earnings Per Share (EPS) of Biocon Ltd is ₹4.48. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Biocon Ltd?

Biocon Ltd has a Return on Equity (ROE) of 0.91%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video